Categories Uncategorized

4 Face Mask Myths

The Centers for Disease Control and Prevention (“CDC”) recently stated that “Cloth face coverings are one of the most powerful weapons we have to slow and stop the spread of the virus,” (https://ibn.fm/1yiUN). However, there are people that believe alternative sources, or unsubstantiated myths, such as those listed below.

  1. Wearing a mask causes carbon dioxide build-up, especially when worn for a long period of time

Some people claim they won’t be able to breathe if they have a mask on. However, there is no scientific truth behind this claim. Take for instance, health care workers, who wear masks for many hours over long periods of time during surgeries without any issues.

  1. Masks only protect other people, not the one wearing it

A mask protects both the individual wearing it as well as those around them. A recent study revealed that if a person has no mask on, their droplets can travel up to 8 feet. With a mask on, the droplets travel less than a foot.

Additionally, a mask keeps your nose and mouth covered. These are the two main ways that infected droplets enter an individual’s body.

  1. Masks with exhalation valves offer the same protection as regular masks and are also more comfortable

Masks that have exhalation valves actually put those around you at risk. This is because the valves expel droplets/germs into the air around you, making them unsafe as they offer minimal protection. They do not limit the spread of coronavirus.

  1. There is no need to observe social distancing guidelines while wearing a mask

These go hand in hand. Properly wearing a mask while practicing social distancing is the most effective way of limiting the spread of COVID-19. If you are in public and you need to remove your mask to eat or drink, you are advised to ensure you are 6 feet apart from other individuals.

Precision medicine companies like Predictive Oncology (NASDAQ: POAI) encourage individuals to follow CDC guidelines so that they don’t fall victim to these myths.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Study Finds That Marijuana Legalization Lowers Crime Rates

David Eby, the Premier of British Columbia, has revealed that a wide range of American healthcare workers,…

3 minutes ago

Earth Science Tech Inc. (ETST) Builds Telehealth, Pharmacy Links in Evolving Digital Care

Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer…

23 hours ago

Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline

High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix…

1 day ago

Mirror-Image Amino Acid Shows Promise in Starving Cancer Cells

Most existing cancer treatments not only attack cancer cells but also adversely impact healthy body cells. The…

2 days ago

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…

3 days ago

Microbial Ecosystems Play a Big Role in the Efficacy of Cancer Immunotherapy

Significant strides have been made in leveraging checkpoint inhibitor therapy to combat a number of cancers over the recent…

6 days ago